From biportal to uniportal video-assisted thoracoscopic anatomical lung resection A single-institute experience

Jia Ming Chang, Kam Hong Kam, Yi Ting Yen, Wei Li Huang, Wei Chen, Yau Lin Tseng, Ming Ho Wu, Wu Wei Lai, Diego Gonzalez-Rivas

研究成果: Article

12 引文 (Scopus)

摘要

Our study sought to review our experience from biportal to uniportal video-assisted thoracoscopic surgery (VATS) major lung resection. Lessons we learned from the evolution regarding technical aspects were also discussed. We retrospectively reviewed patients who underwent VATS lobectomy or segmentectomies in Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan, during January 2012 and December 2014. Patient clinical profiles, surgical indications and procedures, postoperative course, and oncological parameters were analyzed and compared between the biportal and uniportal groups. A total of 121 patients were enrolled in this study with median follow-up of 19.5±11.6 months for all patients and 22.5±11.5 months for primary lung cancer patients. Operation time (146.1±31.9-158.7±40.5 minutes; P=0.077), chest drainage time (3.8± 3.3-4.4±2.4 days; P=0.309), conversion to thoracotomy rate (2.2%-2.6%; P=0.889), and complication rate (15.6%-19.7%; P= 0.564) were equal between the groups, whereas blood loss (96.7±193.2-263.6±367; P=0.006) was lower in the uniportal group. For lung cancer cases, there were no statistical differences in the histology, cancer staging, mediastinal lymph node dissection stations, numbers of dissected N1, N2, and overall lymph nodes between uniportal and biportal groups. Our preliminary data showed that uniportal VATS anatomical lung resection is as feasible, equally safe, and of comparative oncological clearance efficacy to biportal VATS.

原文English
文章編號e5097
期刊Medicine (United States)
95
發行號40
DOIs
出版狀態Published - 2016 一月 1

指紋

Video-Assisted Thoracic Surgery
Lung
Lung Neoplasms
Segmental Mastectomy
Postoperative Care
Neoplasm Staging
Thoracotomy
Blood Group Antigens
Lymph Node Excision
Taiwan
Drainage
Histology
Thorax
Lymph Nodes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

引用此文

@article{247d425f0f3d4cdd95cceb59b863abc6,
title = "From biportal to uniportal video-assisted thoracoscopic anatomical lung resection A single-institute experience",
abstract = "Our study sought to review our experience from biportal to uniportal video-assisted thoracoscopic surgery (VATS) major lung resection. Lessons we learned from the evolution regarding technical aspects were also discussed. We retrospectively reviewed patients who underwent VATS lobectomy or segmentectomies in Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan, during January 2012 and December 2014. Patient clinical profiles, surgical indications and procedures, postoperative course, and oncological parameters were analyzed and compared between the biportal and uniportal groups. A total of 121 patients were enrolled in this study with median follow-up of 19.5±11.6 months for all patients and 22.5±11.5 months for primary lung cancer patients. Operation time (146.1±31.9-158.7±40.5 minutes; P=0.077), chest drainage time (3.8± 3.3-4.4±2.4 days; P=0.309), conversion to thoracotomy rate (2.2{\%}-2.6{\%}; P=0.889), and complication rate (15.6{\%}-19.7{\%}; P= 0.564) were equal between the groups, whereas blood loss (96.7±193.2-263.6±367; P=0.006) was lower in the uniportal group. For lung cancer cases, there were no statistical differences in the histology, cancer staging, mediastinal lymph node dissection stations, numbers of dissected N1, N2, and overall lymph nodes between uniportal and biportal groups. Our preliminary data showed that uniportal VATS anatomical lung resection is as feasible, equally safe, and of comparative oncological clearance efficacy to biportal VATS.",
author = "Chang, {Jia Ming} and Kam, {Kam Hong} and Yen, {Yi Ting} and Huang, {Wei Li} and Wei Chen and Tseng, {Yau Lin} and Wu, {Ming Ho} and Lai, {Wu Wei} and Diego Gonzalez-Rivas",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MD.0000000000005097",
language = "English",
volume = "95",
journal = "Medicine (United States)",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "40",

}

From biportal to uniportal video-assisted thoracoscopic anatomical lung resection A single-institute experience. / Chang, Jia Ming; Kam, Kam Hong; Yen, Yi Ting; Huang, Wei Li; Chen, Wei; Tseng, Yau Lin; Wu, Ming Ho; Lai, Wu Wei; Gonzalez-Rivas, Diego.

於: Medicine (United States), 卷 95, 編號 40, e5097, 01.01.2016.

研究成果: Article

TY - JOUR

T1 - From biportal to uniportal video-assisted thoracoscopic anatomical lung resection A single-institute experience

AU - Chang, Jia Ming

AU - Kam, Kam Hong

AU - Yen, Yi Ting

AU - Huang, Wei Li

AU - Chen, Wei

AU - Tseng, Yau Lin

AU - Wu, Ming Ho

AU - Lai, Wu Wei

AU - Gonzalez-Rivas, Diego

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Our study sought to review our experience from biportal to uniportal video-assisted thoracoscopic surgery (VATS) major lung resection. Lessons we learned from the evolution regarding technical aspects were also discussed. We retrospectively reviewed patients who underwent VATS lobectomy or segmentectomies in Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan, during January 2012 and December 2014. Patient clinical profiles, surgical indications and procedures, postoperative course, and oncological parameters were analyzed and compared between the biportal and uniportal groups. A total of 121 patients were enrolled in this study with median follow-up of 19.5±11.6 months for all patients and 22.5±11.5 months for primary lung cancer patients. Operation time (146.1±31.9-158.7±40.5 minutes; P=0.077), chest drainage time (3.8± 3.3-4.4±2.4 days; P=0.309), conversion to thoracotomy rate (2.2%-2.6%; P=0.889), and complication rate (15.6%-19.7%; P= 0.564) were equal between the groups, whereas blood loss (96.7±193.2-263.6±367; P=0.006) was lower in the uniportal group. For lung cancer cases, there were no statistical differences in the histology, cancer staging, mediastinal lymph node dissection stations, numbers of dissected N1, N2, and overall lymph nodes between uniportal and biportal groups. Our preliminary data showed that uniportal VATS anatomical lung resection is as feasible, equally safe, and of comparative oncological clearance efficacy to biportal VATS.

AB - Our study sought to review our experience from biportal to uniportal video-assisted thoracoscopic surgery (VATS) major lung resection. Lessons we learned from the evolution regarding technical aspects were also discussed. We retrospectively reviewed patients who underwent VATS lobectomy or segmentectomies in Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan, during January 2012 and December 2014. Patient clinical profiles, surgical indications and procedures, postoperative course, and oncological parameters were analyzed and compared between the biportal and uniportal groups. A total of 121 patients were enrolled in this study with median follow-up of 19.5±11.6 months for all patients and 22.5±11.5 months for primary lung cancer patients. Operation time (146.1±31.9-158.7±40.5 minutes; P=0.077), chest drainage time (3.8± 3.3-4.4±2.4 days; P=0.309), conversion to thoracotomy rate (2.2%-2.6%; P=0.889), and complication rate (15.6%-19.7%; P= 0.564) were equal between the groups, whereas blood loss (96.7±193.2-263.6±367; P=0.006) was lower in the uniportal group. For lung cancer cases, there were no statistical differences in the histology, cancer staging, mediastinal lymph node dissection stations, numbers of dissected N1, N2, and overall lymph nodes between uniportal and biportal groups. Our preliminary data showed that uniportal VATS anatomical lung resection is as feasible, equally safe, and of comparative oncological clearance efficacy to biportal VATS.

UR - http://www.scopus.com/inward/record.url?scp=84995608783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995608783&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000005097

DO - 10.1097/MD.0000000000005097

M3 - Article

C2 - 27749589

AN - SCOPUS:84995608783

VL - 95

JO - Medicine (United States)

JF - Medicine (United States)

SN - 0025-7974

IS - 40

M1 - e5097

ER -